Jae Seok Park

Jae Seok Park

Auto-generated profile, based on publicly available information

Jae Seok Park

Division of Pulmonary Medicine, Department of Internal Medicine, Keimyung University Dongsan Medical Center, Daegu, South Korea

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2017 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
YKYong Shik Kwon
Yong Shik Kwon
SPSun Hyo Park
Sun Hyo Park
MKMi-Ae Kim
Mi-Ae Kim
HKHyun Jung Kim
Hyun Jung Kim
JPJae Seok Park
Jae Seok Park
WCWon-Il Choi
Won-Il Choi
Respiratory syncytial virus (RSV) infection constitutes a substantial disease burden in the general population. However, the risk of death for RSV infection has been rarely evaluated with confounders or comorbidities adjusted. We aimed to evaluate whether RSV infection is associated with higher mortality than seasonal influenza after adjusting for confounders and comorbidities and the effect of oseltamivir on the mortality in patients with influenza infection. A retrospective cohort study was conducted on adult (≥18 years) patients admitted to the emergency department and ward of a university teaching hospital for suspected viral infection during 2013–2015 (N = 3743). RSV infection was diagnosed by multiplex PCR (N = 87). Adults hospitalized for seasonal influenza during the study period were enrolled as a comparison group (n = 312). The main outcome was 20-day all-cause mortality.We used Cox proportional hazard regression analyses to calculate the relative risk of death. Adult patients were less likely to be diagnosed with RSV than with influenza (2.3 vs 8.3%, respectively), were older and more likely to be diagnosed with pneumonia, chronic obstructive pulmonary disease, hypoxemia, and bacterial co-infection. In patients with RSV infection, the 20-day all-cause mortality was higher than that for influenza, (18.4 vs 6.7%, respectively). RSV infection showed significantly higher risk of death compared to the seasonal influenza group, with hazard ratio, 2.32 (95% CI, 1.17–4.58). Oseltamivir had no significant effect on mortality in patients with influenza. RSV infection was significantly associated with a higher risk of death than seasonal influenza, adjusted for potential confounders and comorbidities.

4 June 2018 in BMC Pulmonary Medicine
Verified
Journal Article
Open access
PDF file
WCWon-Il Choi
Won-Il Choi
SDSonila Dauti
Sonila Dauti
HKHyun Jung Kim
Hyun Jung Kim
SPSun Hyo Park
Sun Hyo Park
JPJae Seok Park
Jae Seok Park
CLChoong Won Lee
Choong Won Lee
Understanding the risk factors that are associated with the development of interstitial lung disease might have an important role in understanding the pathogenetic mechanism of interstitial lung disease as well as prevention. We aimed to determine independent risk factors of interstitial lung disease development. This was a retrospective cohort study with nationwide population-based 9-year longitudinal data. We selected subjects who were aged > 40 years at cohort entry and with a self-reported history of cigarette smoking. Cases were selected based on International Classification of Diseases codes. A cohort of 312,519 subjects were followed until December 2013. We used Cox regression analysis to calculate the hazard ratios (HRs) for interstitial lung disease development. Interstitial lung disease developed in 1972 of the 312,519 subjects during the 9-year period. Smoking (HR: 1.2; 95% confidence interval [CI]: 1.1–1.4), hepatitis C (HR: 1.6; 95% CI: 1.1–2.3), history of tuberculosis (HR: 1.5; 95% CI: 1.1–1.9), history of pneumonia (HR: 1.6; 95% CI: 1.3–2.0), and chronic obstructive pulmonary disease (HR: 1.8; 95% CI: 1.6–2.1), men (HR: 1.9; 95% CI: 1.7–2.1) were significantly associated with the development of interstitial lung disease. The risk of interstitial lung disease development increases with age, and the risk was 6.9 times higher (95% CI: 5.9–8.0) in those aged over 70 than in their forties. Smoking, hepatitis C, history of tuberculosis, history of pneumonia, chronic obstructive pulmonary disease, male sex, and older age were significantly associated with interstitial lung disease development.

1 January 2020 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
YCYoungJun Chon
YoungJun Chon
JKJin Young Kim
Jin Young Kim
YSYoung Joo Suh
Young Joo Suh
JLJi Yeon Lee
Ji Yeon Lee
JPJae Seok Park
Jae Seok Park
JYJaehyuck Yi
Jaehyuck Yi
Chon Y, et al. J Korean Med Sci. 2020 Jul;35(34):e316. https://doi.org/10.3346/jkms.2020.35.e316

29 July 2024 in Cancer Research
Verified
Journal Article
Closed access
PDF file
MPMihyang Park
Mihyang Park
JJJonghwa Jin
Jonghwa Jin
DADa Young An
Da Young An
DKDong-Ho Kim
Dong-Ho Kim
JLJaebon Lee
Jaebon Lee
KPKeun-Gyu Park
Keun-Gyu Park
Cancer cells use multiple mechanisms to evade the effects of glutamine metabolism inhibitors. The pathways that govern responses to alterations in glutamine availability within the tumor may represent therapeutic targets for combinatorial strategies with these inhibitors. Here, we showed that targeting glutamine utilization stimulated Yes-associated protein (YAP) signaling in cancer cells by reducing cyclic adenosine monophosphate/protein kinase A (PKA)–dependent phosphorylation of large tumor suppressor (LATS). Elevated YAP activation induced extracellular matrix (ECM) deposition by increasing the secretion of connective tissue growth factor that promoted the production of fibronectin and collagen by surrounding fibroblasts. Consequently, inhibiting YAP synergized with inhibition of glutamine utilization to effectively suppress tumor growth in vivo, along with a concurrent decrease in ECM deposition. Blocking ECM remodeling also augmented the tumor suppressive effects of the glutamine utilization inhibitor. Collectively, these data reveal mechanisms by which targeting glutamine utilization increases ECM accumulation and identify potential strategies to reduce ECM levels and increase the efficacy of glutamine metabolism inhibitors. Significance: Blocking glutamine utilization activates YAP to promote ECM deposition by fibroblasts, highlighting the potential of YAP inhibitors and antifibrotic strategies as promising approaches for effective combination metabolic therapies in cancer.

1 January 2020 in Korean Journal of Radiology
Verified
Journal Article
Open access
PDF file
HJHa Kyung Jung
Ha Kyung Jung
JKJin Young Kim
Jin Young Kim
MLMu Sook Lee
Mu Sook Lee
JLJi Yeon Lee
Ji Yeon Lee
JPJae Seok Park
Jae Seok Park
YSYoung Joo Suh
Young Joo Suh
Jung HK, et al. Korean J Radiol. 2020 Jul;21:e121. https://doi.org/10.3348/kjr.2020.0564

Verified
Journal Article
Open access
PDF file
JPJaeseok Park
Jaeseok Park
YKYong-Shik Kwon
Yong-Shik Kwon
HKHyun ah Kim
Hyun ah Kim
DKDoo Hyuk Kwon
Doo Hyuk Kwon
JHJihye Hwang
Jihye Hwang
JHJeong-Ho Hong
Jeong-Ho Hong
Clinical implications of neurological problems during intensive care unit (ICU) care for coronavirus disease 2019 (COVID-19) patients are unknown. This study aimed to describe the clinical implications of preexisting neurological comorbidities and new-onset neurological complications in ICU patients with COVID-19. ICU patients who were isolated and treated for COVID-19 between 19 February 2020 and 3 May 2020, from one tertiary hospital and one government-designated branch hospital were included. Clinical data including previous neurological disorders were extracted from electronic medical records. All neurological complications were evaluated by neurointensivists. Multiple logistic regression analysis was performed to investigate independent factors in ICU mortality. The median age of 52 ICU patients with COVID-19 was 73 years. Nineteen (36.5%) patients had preexisting neurological comorbidities, and new-onset neurological complications occurred in 23 (44.2%) during ICU admission. Patients with preexisting neurological comorbidities required tracheostomy more frequently and more ventilator and ICU days than those without. Patients with new-onset neurological complications experienced more medical complications and had higher ICU severity score and ICU mortality rates. New-onset neurological complications remained an independent factor for ICU mortality. Many COVID-19 patients in the ICU have preexisting neurological comorbidities, making them at a high risk of new-onset neurological complications.